Provided by Tiger Trade Technology Pte. Ltd.

Vir Biotechnology, Inc.

10.58
-0.2300-2.13%
Post-market: 10.51-0.0700-0.66%16:54 EDT
Volume:1.86M
Turnover:19.71M
Market Cap:1.78B
PE:-6.23
High:10.79
Open:10.57
Low:10.45
Close:10.81
52wk High:11.94
52wk Low:4.75
Shares:168.65M
Float Shares:130.00M
Volume Ratio:0.90
T/O Rate:1.43%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6972
EPS(LYR):-3.1619
ROE:-26.08%
ROA:-14.51%
PB:1.82
PE(LYR):-3.35

Loading ...

Feb 24, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 30, 2025

Major Issues Report

Form 8-K - Current report
Jan 08, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 08, 2025

Major Issues Report

Form 8-K - Current report
Dec 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 06, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 05, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 01, 2024

Major Issues Report

Form 8-K - Current report
Oct 18, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Sep 10, 2024

Major Issues Report

Form 8-K - Current report
Sep 10, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 01, 2024

Major Issues Report

Form 8-K - Current report
Aug 01, 2024

Major Issues Report

Form 8-K - Current report
Aug 01, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 10, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 26, 2024

Major Issues Report

Form 8-K - Current report
Jun 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities